Scientific publications
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI). Scientific Publication
María Eva Mingot-Castellano 1 , Mariana Canaro Hirnyk 2 , Blanca Sánchez-González 3 , María Teresa Álvarez-Román 4 , Abelardo Bárez-García 5 , Ángel Bernardo-Gutiérrez 6 , Silvia Bernat-Pablo 7 , Estefanía Bolaños-Calderón 8 , Nora Butta-Coll 9 , Gonzalo Caballero-Navarro 10 , Isabel Socorro Caparrós-Miranda 11 , Laura Entrena-Ureña 12 , Luis Fernando Fernández-Fuertes 13 , Luis Javier García-Frade 14 , María Del Carmen Gómez Del Castillo 15 , Tomás José González-López 16 , Carlos Grande-García 17 , José María Guinea de Castro 18 , Isidro Jarque-Ramos 19 , Reyes Jiménez-Bárcenas 20 , Elsa López-Ansoar 21 , Daniel Martínez-Carballeira 6 , Violeta Martínez-Robles 22 , Emilio Monteagudo-Montesinos 23 , José Antonio Páramo-Fernández 24 , María Del Mar Perera-Álvarez 25 , Inmaculada Soto-Ortega 6 , David Valcárcel-Ferreiras 26 , Cristina Pascual-Izquierdo 27 28 ; Spanish Immune Thrombocytopenia Group (GEPTI)
Abstract
Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management.
In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since.
Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately.
Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.
CITATION J Clin Med. 2023 Oct 10;12(20):6422. doi: 10.3390/jcm12206422
Our authors
